Gaku Tsuji Selected Research

Psoriatic Arthritis

8/2019

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gaku Tsuji Research Topics

Disease

26	Atopic Dermatitis (Atopic Eczema) 02/2024 - 02/2015
17	Inflammation (Inflammations) 09/2023 - 05/2015
12	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2023 - 04/2011
9	Skin Diseases (Skin Disease) 09/2023 - 04/2011
8	Neoplasms (Cancer) 02/2023 - 11/2010
7	Pruritus (Itching) 02/2024 - 12/2017
5	Dermatitis 03/2022 - 01/2018
4	Chloracne 01/2021 - 07/2018
4	Extramammary Paget Disease (Paget Disease, Extramammary) 10/2011 - 03/2010
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2019 - 12/2010
2	Melanoma (Melanoma, Malignant) 02/2023 - 07/2011
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 11/2021 - 01/2021
2	Cough 01/2021 - 11/2014
2	Hyperpigmentation 01/2021 - 12/2019
2	Necrosis 01/2018 - 01/2018
2	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2015 - 01/2009
2	Carcinogenesis 12/2013 - 07/2011
1	Eczema 02/2024
1	Conjunctivitis 12/2023
1	Blepharitis 12/2023
1	Disease Progression 11/2021
1	Hypesthesia (Numbness) 01/2021
1	Poisoning 01/2021
1	Paresthesia (Dysesthesia) 01/2021
1	Hypertriglyceridemia 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021
1	Neurofibroma 01/2021
1	Hyperplasia 01/2020
1	Benign Fibrous Histiocytoma (Dermatofibroma) 09/2019
1	Psoriatic Arthritis 08/2019
1	Wounds and Injuries (Trauma) 07/2019

Drug/Important Bio-Agent (IBA)

8	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 09/2023 - 02/2015
6	Filaggrin ProteinsIBA 03/2022 - 01/2017
6	DioxinsIBA 01/2021 - 10/2013
6	Interleukin-17 (Interleukin 17)IBA 11/2020 - 01/2018
5	CytokinesIBA 01/2022 - 06/2019
5	InterleukinsIBA 01/2022 - 01/2018
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2011
4	Biomarkers (Surrogate Marker)IBA 02/2024 - 08/2019
4	dupilumabIBA 12/2023 - 06/2019
4	Interleukin-13IBA 09/2020 - 06/2019
3	Interleukin-33IBA 09/2023 - 03/2020
3	tapinarofIBA 01/2022 - 10/2019
3	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 11/2021 - 09/2019
3	Endothelin-1 (Endothelin 1)IBA 01/2021 - 07/2011
3	Chemokine CCL17IBA 01/2021 - 11/2016
3	ChemokinesIBA 01/2020 - 10/2013
3	LigandsIBA 12/2019 - 11/2016
3	Interleukin-4 (Interleukin 4)IBA 12/2019 - 06/2019
3	Immunoglobulin E (IgE)IBA 07/2017 - 04/2015
2	Phosphodiesterase 4 InhibitorsIBA 05/2023 - 12/2017
2	Interleukin-23 (Interleukin 23)IBA 11/2021 - 01/2018
2	Metformin (Glucophage)FDA LinkGeneric 11/2021 - 01/2020
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2021 - 01/2021
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2021 - 11/2020
2	Imiquimod (Aldara)FDA LinkGeneric 11/2020 - 01/2020
2	glyteenIBA 04/2018 - 02/2015
2	Cathepsin KIBA 01/2011 - 05/2010
2	matrigelIBA 01/2011 - 12/2010
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2024
1	Chemokine CCL26IBA 02/2024
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 05/2023
1	difamilastIBA 05/2023
1	ErbB Receptors (EGF Receptor)IBA 02/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2023
1	AlarminsIBA 01/2022
1	Thymic Stromal LymphopoietinIBA 02/2021
1	LipidsIBA 02/2021
1	bafilomycin AIBA 01/2021
1	U 0126 (UO 126)IBA 01/2021
1	2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamideIBA 01/2021
1	Bosentan (Tracleer)FDA Link 01/2021
1	Antimalarials (Antimalarial Agents)IBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	CollagenIBA 01/2021
1	Polychlorinated Biphenyls (PCBs)IBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	Neurofibromin 1 (Neurofibromin)IBA 01/2021
1	Metalloproteases (Metalloproteinases)IBA 01/2021
1	Endothelin Receptor AntagonistsIBA 01/2021
1	loricrinIBA 12/2020
1	Endothelin A ReceptorIBA 11/2020
1	Interleukin-12 (IL 12)IBA 11/2020
1	Endothelin Receptors (Endothelin Receptor)IBA 11/2020
1	ambrisentan FDA Link 11/2020
1	Vasoconstrictor AgentsIBA 11/2020
1	Interleukin-1 (Interleukin 1)IBA 03/2020
1	Antimicrobial PeptidesIBA 02/2020
1	InflammasomesIBA 01/2020
1	EnzymesIBA 12/2019
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 12/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2019
1	squamous cell carcinoma-related antigenIBA 08/2019
1	AntigensIBA 08/2019
1	Interleukin-6 (Interleukin 6)IBA 04/2019
1	SmokeIBA 04/2019
1	Environmental Pollutants (Pollutants, Environmental)IBA 04/2019

Therapy/Procedure

3	Therapeutics 02/2023 - 02/2017
2	Ligation 12/2019 - 01/2018
1	Precision Medicine 02/2024